Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.66 USD | +3.29% | -6.56% | +0.23% |
08/05 | Syndax Pharmaceuticals Q1 Net Loss Widens | MT |
08/05 | Transcript : Syndax Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.23% | 184.08Cr | |
+29.03% | 4.92TCr | |
-0.10% | 4.21TCr | |
+49.56% | 4.04TCr | |
-5.26% | 2.89TCr | |
+11.48% | 2.61TCr | |
-22.74% | 1.87TCr | |
+9.06% | 1.33TCr | |
+30.01% | 1.23TCr | |
-1.51% | 1.2TCr |
- Stock Market
- Equities
- SNDX Stock
- News Syndax Pharmaceuticals, Inc.
- Goldman Sachs Adjusts Price Target on Syndax Pharmaceuticals to $39 From $35, Maintains Buy Rating